Sheryl Martin-Schild, M.D., Ph.D., FANA, FAHA

Sheryl Martin-Schild, M.D., Ph.D., FANA, FAHA

Dr. Martin-Schild graduated from the Tulane University School of Medicine, while also obtaining her PhD in Neuroscience. Dr. Martin-Schild completed a combined internal medicine and neurology residency at Tulane University School of Medicine, followed by fellowship training in Vascular Neurology and clinical research in Vascular Neurology at the University of Texas Health Science Center in Houston, Texas. Dr. Martin-Schild founded and directed the Stroke Program at Tulane Medical Center 2008-2016. She advanced Tulane Medical Center to Primary Stroke Center level in less than 2 years from inception and Comprehensive Stroke Center 3 years later. Her service delivered the highest rate of and most efficient with thrombolytic treatment for ischemic stroke in Louisiana.

Dr. Martin-Schild’s research focuses on access to stroke care, racial disparities in outcome, and augmentation of rehabiliation potential with neurostimulants. She has more than 100 manuscripts published in peer-reviewed journals. Dr. Martin-Schild serves as the Statewide Stroke Medical Director for the Louisiana Emergency Response Network. She is the President & CEO of Dr. Brain, Inc., which provides on-site stroke leadership and patient care to hospitals committed to improving or developing stroke programs. She currently serves as the Medical Director of Neurology & Stroke for Touro Infirmary and the New Orleans East Hospital and Co-Director of Stroke for Our Lady of the Lake in Baton Rouge. She will serve as PI for Southeast Louisiana’s satellites and high-performance sites, through UT-Houston’s Regional Coordinating Center, for the National Institute of Health (NIH) funded StrokeNet.

Selected Publications

  1. Siegler JE, George AJ, Martin-Schild S. Reexpression of Prior Stroke Symptoms in Adults: When is a Mimic a Mimic? Neurologist. 2017 Sep;22(5):199-203. PubMed PMID: 28859026.
  2. Siegler JE, Albright KC, George AJ, Boehme AK, Gillette MA, Kumar AD, Aswani M, Martin-Schild S. Time to Neurological Deterioration in Ischemic Stroke. Med Student Res J. 2017 Winter;4:18-24. PubMed PMID: 28804679; PubMed Central PMCID: PMC5553982.
  3. Shaban A, Monlezun DJ, Rincon N, Tiu J, Valmoria M, Martin-Schild S. Safety and Efficacy of Acute Clopidogrel Load in Patients with Moderate and Severe Ischemic Strokes. Stroke Res Treat. 2016; 2016:8915764. PubMed PMID: 27818831; PubMed Central PMCID: PMC5081427.
  4. Boehme AK, Martin-Schild S, Marshall RS, Lazar RM. Effect of aphasia on acute stroke outcomes. Neurology. 2016 Nov 29;87(22):2348-2354. PubMed PMID: 27765864; PubMed Central PMCID: PMC5135027.
  5. Siegler JE, Martin-Schild S. Intravenous Thrombolysis Attenuates Neurologic Deterioration After Ischemic Stroke. South Med J. 2016 Oct;109(10):661-667. PubMed PMID: 27706507.
  6. Siegler JE, Samai A, Semmes E, Martin-Schild S. Early Neurologic Deterioration after Stroke Depends on Vascular Territory and Stroke Etiology. J Stroke. 2016 May;18(2):203-10. PubMed PMID: 27283280; PubMed Central PMCID: PMC4901951.
  7. Anaissie J, Monlezun D, Seelochan A, Siegler JE, Chavez-Keatts M, Tiu J, Pineda D, George A, Shaban A, Abi Rafeh N, Schluter L, Martin-Schild S, El Khoury R. Left Atrial Enlargement on Transthoracic Echocardiography Predicts Left Atrial Thrombus on Transesophageal Echocardiography in Ischemic Stroke Patients. Biomed Res Int. 2016;2016:7194676. PubMed PMID: 27822477; PubMed Central PMCID: PMC5086361.
  8. Shaban A, Monlezun DJ, Rincon N, Tiu J, Valmoria M, Martin-Schild S. Safety and Efficacy of Acute Clopidogrel Load in Patients with Moderate and Severe Ischemic Strokes. Stroke Res Treat. 2016;2016:8915764. PubMed PMID: 27818831; PubMed Central PMCID: PMC5081427.
  9. Montalvo M, Tadi P, Merkler A, Gialdini G, Martin-Schild S, Navalkele D, Samai A, Nouh A, Hussain M, Goldblatt S, Hemendinger M, Chu A, Song C, Kamel H, Furie KL, Yaghi S. PR Interval Prolongation and Cryptogenic Stroke: A Multicenter Retrospective Study. J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2416-2420. PubMed PMID: 28666806.
  10. Yaghi S, Boehme AK, Dibu J, Leon Guerrero CR, Ali S, Martin-Schild S, Sands KA, Noorian AR, Blum CA, Chaudhary S, Schwamm LH, Liebeskind DS, Marshall RS, Willey JZ. Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective Study. JAMA Neurol. 2015 Dec;72(12):1451-7. PubMed PMID: 26501741; PubMed Central PMCID: PMC4845894.
  11. Scullen TA, Monlezun DJ, Siegler JE, George AJ, Schwickrath M, El Khoury R, Cho MC, Martin-Schild S. Cryptogenic stroke: clinical consideration of a heterogeneous ischemic subtype. J Stroke Cerebrovasc Dis. 2015 May;24(5):993-9. PubMed PMID: 25813058.
  12. Marx MH, Albright KC, Shaban A, Boehme AK, Beasley TM, Martin-Schild S. Social History Matters-The Impact of Illicit Drug Use on tPA Use and In-Hospital Mortality in Acute Ischemic Stroke. Int Neuropsychiatr Dis J. 2014 May;2(3):127-135. PubMed PMID: 25436216; PubMed Central PMCID: PMC4245033.
  13. Yaghi S, Rostanski SK, Boehme AK, Martin-Schild S, Samai A, Silver B, Blum CA, Jayaraman MV, Siket MS, Khan M, Furie KL, Elkind MS, Marshall RS, Willey JZ. Imaging Parameters and Recurrent Cerebrovascular Events in Patients With Minor Stroke or Transient Ischemic Attack. JAMA Neurol. 2016 May 1;73(5):572-8. PubMed PMID: 26998948; PubMed Central PMCID: PMC5022560.
  14. Bush CK, Kurimella D, Cross LJ, Conner KR, Martin-Schild S, He J, Li C, Chen J, Kelly T. Endovascular Treatment with Stent-Retriever Devices for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. PLoS One. 2016 Jan 25;11(1):e0147287. eCollection 2016. PubMed PMID: 26807742; PubMed Central PMCID: PMC4726653.
  15. Samai AA, Martin-Schild S. Sex differences in predictors of ischemic stroke: current perspectives. Vasc Health Risk Manag. 2015 Jul 27;11:427-36. PubMed PMID: 26251609; PubMed Central PMCID: PMC4524454.
  16. Crisan D, Shaban A, Boehme A, Dubin P, Juengling J, Schluter LA, Albright KC, Beasley TM, Martin-Schild S. Predictors of recovery of functional swallow after gastrostomy tube placement for Dysphagia in stroke patients after inpatient rehabilitation: a pilot study. Ann Rehabil Med. 2014 Aug;38(4):467-75. PubMed PMID: 25229025; PubMed Central PMCID: PMC4163586.
  17. Vahidy FS, Hicks WJ 2nd, Acosta I, Hallevi H, Peng H, Pandurengan R, Gonzales NR, Barreto AD, Martin-Schild S, Wu TC, Rahbar MH, Bambhroliya AB, Grotta JC, Savitz SI. Neurofluctuation in patients with subcortical ischemic stroke. Neurology. 2014 Jul 29;83(5):398-405. PubMed PMID: 24966405; PubMed Central PMCID: PMC4132571.
  18. Tsivgoulis G, Putaala J, Sharma VK, Balucani C, Martin-Schild S, Giannopoulos S, Batala L, Krogias C, Palazzo P, Bavarsad Shahripour R, Arvaniti C, Barlinn K, Strbian D, Haapaniemi E, Flamouridou M, Vadikolias K, Heliopoulos I, Voumvourakis K, Triantafyllou N, Azarpazhooh MR, Athanasiadis D, Kosmidou M, Katsanos AH, Vasdekis SN, Stefanis L, Stamboulis E, Piperidou C, Tatlisumak T, Alexandrov AV. Racial disparities in early mortality in 1,134 young patients with acute stroke. Neurol Sci. 2014 Jul;35(7):1041-9. PubMed PMID: 24469348.
  19. Boehme AK, Siegler JE, Mullen MT, Albright KC, Lyerly MJ, Monlezun DJ, Jones EM, Tanner R, Gonzales NR, Beasley TM, Grotta JC, Savitz SI, Martin-Schild S. Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014 Apr;23(4):e255-61. doi: 10.1016/j.jstrokecerebrovasdis.2013.11.003. Epub 2014 Jan 25. PubMed PMID: 24468069; PubMed Central PMCID: PMC3989836.
  20. Siegler JE, Boehme AK, Albright KC, George AJ, Monlezun DJ, Beasley TM, Martin-Schild S. A proposal for the classification of etiologies of neurologic deterioration after acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e549-56. PubMed PMID: 23867039; PubMed Central PMCID: PMC4778246.
  21. Siegler JE, Boehme AK, Kumar AD, Gillette MA, Albright KC, Beasley TM, Martin-Schild S. Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e207-13. PubMed PMID: 23246190; PubMed Central PMCID: PMC3690312.
  22. Shulkin DJ, Jewell KE, Alexandrov AW, Bernard DB, Brophy GM, Hess DC, Kohlbrenner J, Martin-Schild S, Mayer SA, Peacock WF, Qureshi AI, Sung GY, Lyles A. Impact of systems of care and blood pressure management on stroke outcomes. Popul Health Manag. 2011 Dec;14(6):267-75. PubMed PMID: 21506730.
  23. Martin-Schild S, Albright KC, Tanksley J, Pandav V, Jones EB, Grotta JC, Savitz SI. Zero on the NIHSS does not equal the absence of stroke. Ann Emerg Med. 2011 Jan;57(1):42-5. PubMed PMID: 20828876; PubMed Central PMCID: PMC3426834.
  24. Barreto AD, Martin-Schild S, Hallevi H, Morales MM, Abraham AT, Gonzales NR, Illoh K, Grotta JC, Savitz SI. Thrombolytic therapy for patients who wake-up with stroke. Stroke. 2009 Mar;40(3):827-32. PubMed PMID: 19131657; PubMed Central PMCID: PMC2676861.
  25. Martin-Schild S. Blood pressure in acute stroke: lower it or let the CHHIPS fall where they will. Lancet Neurol. 2009 Jan;8(1):23-4. PubMed PMID: 19058761.
Share